Machinery & Materials
Logistics & Cold Chain
More from Novartis
FDA Approves Most Expensive Drug in History
The FDA just approved a new drug to treat a rare and deadly genetic disorder, and it costs more than $2 million.
Jun 5th, 2019
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Feb 28th, 2019
Novartis and Sandoz Recall Non-Compliant Blister Packs
The prescription drugs were not in child resistant packaging, which put them in violation of the Poison Prevention Packaging Act.
Jul 19th, 2018
Novartis Enters EpiPen Game With Adamis Deal
Novartis’ Sandoz unit acquires U.S. rights to Symjepi, the prefilled epinephrine syringe from Adamis Pharmaceuticals.
Jul 16th, 2018
WHO Says “Serious Lack” of New Antibiotics in Development
As resistance to existing antibiotics increases, the World Health Organization warns of antibiotic shortage on the horizon.
Sep 28th, 2017
Good News: FDA Approves Gene Therapy for Cancer. Bad News: It Costs $475k
The FDA has approved Novartis’ “first gene therapy” in the U.S. designed to treat blood and bone marrow cancer in children and young adults.
Sep 14th, 2017
Top 10 Patent Cliffs of 2017
Patent expiration is clearing a path for generics to take over; here’s a look at the top 10 patents expiring this year.
Feb 22nd, 2017
Trump to Pharma: Lower Prices & Fewer Regulations
President Trump met with Big Pharma players to discuss lowering prices and bringing drug manufacturing back to the U.S.
Feb 1st, 2017
Spasm Medicine Goes From $40 to $34,000
Mallinckrodt will pay $100 million settlement after raising price of infantile spasm medication 85,000%.
Jan 23rd, 2017